Effects of IL‐1 receptor accessory protein on IL‐1 binding
Open Access
- 16 June 1998
- journal article
- Published by Wiley in FEBS Letters
- Vol. 429 (3) , 303-306
- https://doi.org/10.1016/s0014-5793(98)00468-2
Abstract
Interleukin‐1 (IL‐1) is an important pro‐inflammatory cytokine that exerts its diverse biological functions by binding to a receptor complex consisting of two transmembrane proteins, type I IL‐1 receptor (IL‐1RI) and IL‐1 receptor accessory protein (IL‐1RAcP). Both receptor chains are indispensable for IL‐1 signaling, but only IL‐1RI is able to bind the cytokine. The effects of IL‐1RAcP on IL‐1 binding are unclear. This study shows that although expression of IL‐1RAcP does not alter the equilibrium dissociation constant of IL‐1, it has an effect on the non‐equilibrium binding modus, most likely due to changes in on/off rates. This defines an additional function of IL‐1RAcP: it stabilizes the active IL‐1 receptor complex.Keywords
This publication has 19 references indexed in Scilit:
- The Interleukin-1 Receptor Accessory Protein (IL-1RAcP) Is Essential for IL-1-induced Activation of Interleukin-1 Receptor-associated Kinase (IRAK) and Stress-activated Protein Kinases (SAP Kinases)Journal of Biological Chemistry, 1997
- A new cytokine-receptor binding mode revealed by the crystal structure of the IL-1 receptor with an antagonistNature, 1997
- Crystal structure of the type-I interleukin-1 receptor complexed with interleukin-1βNature, 1997
- A critical role for interleukin‐1 receptor accessory protein in interleukin‐1 signalingEuropean Journal of Immunology, 1997
- TRAF6 is a signal transducer for interleukin-1Nature, 1996
- Co-expression of mRNA for type I and type II Interleukin-1 receptors and the IL-1 receptor accessory protein correlates to IL-1 responsivenessFEBS Letters, 1996
- Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4Science, 1993
- Interleukin 1 signaling occurs exclusively via the type I receptor.Proceedings of the National Academy of Sciences, 1993
- Conversion of the interleukin 1 receptor antagonist into an agonist by site-specific mutagenesis.Proceedings of the National Academy of Sciences, 1991
- Internalization of interleukin 1 (IL 1) correlates with IL 1‐induced IL 2 receptor expression and IL 2 secretion of EL4 thymoma cellsEuropean Journal of Immunology, 1989